During treatment, levels of serum calcium increased significantly (p < 0.05), three OA patients (1.71%) developed hypercalcemia (Ca > 10.5 mg/dL) and PTH decreased significantly (p < 0.05) after vitamin D2 supplementation. Here, PTH is linked to hypercalcemia disease.